Deformity Market to Capture a CAGR of 7.1% during 2017-2023

Market Overview:
The global Deformity Market is growing at an incremental pace and is expected to register a moderate CAGR of approximately 7.1% over the forecast period of 2017-2023, asserts market Research Future (MRFR) in a detailed research report. Deformity is an abnormality caused in the shape of any organ or body part. It might be caused due to various reasons such as genetic mutation, reconstructive surgery following a severe injury, hormonal disorder or maybe be present at birth. A significant rise has been observed in the prevalence of deformity over the last few years and is the primary factor driving the growth of the global deformity market. The Physicians Committee reports that approximately 3% of all children born in the U.S. suffer major malformations at birth. In addition, each year, over 150000 babies are born with congenital disabilities. High healthcare spends on a global scale has been pivotal in shaping the global deformity market. With better medical facilities purveyed by the development of imaging technology, the market is likely to proliferate over the forecast period. Substantial outlay on the development of innovative treatment options by the key players of the market has also added fuel to the growth of the market. The rise in a number of FDA approvals complement such innovations and augment the growth of the global deformity market. As an add-on, governments and non-profit organizations are also showing interest in spreading awareness regarding the disease and are actively providing support for R&D activities. This can also play a driving factor in the advancement of the global deformity market. There is no particular treatment available for deformity due to which the costs associated with surgery and treatment is very high which can hamper the growth of the global deformity market.
Competitive Landscape
·         SpineCraft
·         Lineage Medical
·         Johnson & Johnson Services Inc
·         Stryker Corporation
·         NuVasive
·         Bristol-Myers Squibb and Company
·         OrthoPediatrics Corp
·         3M
·         Pfizer Inc
·         Argon Medical Devices
·         B. Braun
·         DePuy Synthes
·         Cook Medical

Segmentation
·         The global deformity market has been segmented based on types, therapy, and end users.
·         By types, the global deformity market has been segmented into congenital, and acquired.
·         By therapy, the global deformity market has been segmented into diagnosis and treatment. The diagnosis segment has been further segmented into MRI, CT scan, bone scan, and others.
·         By end users, the market has been segmented hospital & clinics, orthopedic care centers, and others.

Regional Analysis
The global deformity market spans across the regions of the Americas, Europe, Asia Pacific, and the Middle East & Africa.  The Americas account for the largest share of the global deformity market due to the high prevalence of deformity in the region. Additionally, high healthcare spends, government support for R&D activities and availability of funds for R&D spurs the growth of the market in the region. Europe is the second largest market for deformity, followed by the Asia Pacific. High research & Development activities support the growth of the Europe deformity market, the UK, Germany, and France being the key contributors to the market. Asia Pacific is slated to emerge as the fastest growing market for deformity. Increasing patient population, growing healthcare expenditure are the market drivers, India and China being the major shareholders of the Asia Pacific deformity market. The Middle East & Africa hold the least market share due to poor economic conditions, especially in the Africa region. However, with raising awareness and rising investment on healthcare, the market is expected to expand over the forecast period.

Industry Updates
·         In September 2018, SpineVision, a spinal technology company focused on the development and marketing of implants, announced that it had received CE mark approval for its new spine deformity correction system. The Pivot Link Universal System features clip technology, and the system will be introduced at EuroSpine 2018 in Barcelona, Spain, September.

In September 2018, AMDT Holdings, Inc., a medical technology company, announced FDA clearance for their deformity analysis and correction software and instrumentation, SixFix deformity system.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more